Literature DB >> 34508506

COVID-19 Reinfection in a Young Medical Doctor: A Case Report.

Dhruba Gaire1, Muneshwar Sah1, Bishnu Singh2.   

Abstract

There is hardly any report of reinfection due to coronavirus disease 2019 (COVID-19) in medical professionals from Nepal. We report a case of a 32-year-old doctor with COVID-19 reinfection. Symptoms during the first infection were mild. After one month, he was reinfected and developed diarrhea as well as a continuous high fever. His d-dimer and ferritin were much increased. Computed tomography chest showed bilateral lymph nodes, minimal pleural effusion, and scattered linear fibrosis. After discharge, his depression and myalgia persisted for one month. During reinfection, his symptoms were more severe and cost of treatment was almost eight times his monthly salary and he could not work for six weeks. Possible reasons for severe reinfection and differential diagnoses like cytokine storm, multisystem inflammatory syndrome, reactivation of COVID-19, and infection due to new variants were discussed. Whether infected or vaccinated or not, all should take recommended vaccination and primary-preventive as well as health-promotive measures.

Entities:  

Mesh:

Year:  2021        PMID: 34508506      PMCID: PMC9107853          DOI: 10.31729/jnma.6450

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.556


  9 in total

1.  What we know about covid-19 reinfection so far.

Authors:  Chris Stokel-Walker
Journal:  BMJ       Date:  2021-01-19

2.  International Diabetes Federation: a consensus on Type 2 diabetes prevention.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2007-05       Impact factor: 4.359

3.  Seasonal coronavirus protective immunity is short-lasting.

Authors:  Arthur W D Edridge; Joanna Kaczorowska; Alexis C R Hoste; Margreet Bakker; Michelle Klein; Katherine Loens; Maarten F Jebbink; Amy Matser; Cormac M Kinsella; Paloma Rueda; Margareta Ieven; Herman Goossens; Maria Prins; Patricia Sastre; Martin Deijs; Lia van der Hoek
Journal:  Nat Med       Date:  2020-09-14       Impact factor: 53.440

4.  Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.

Authors:  Aidan T Hanrath; Brendan A I Payne; Christopher J A Duncan
Journal:  J Infect       Date:  2020-12-26       Impact factor: 6.072

5.  Multisystem Inflammatory Syndrome in Adults: Coming Into Focus.

Authors:  Mark W Tenforde; Sapna Bamrah Morris
Journal:  Chest       Date:  2020-10-30       Impact factor: 9.410

6.  Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

Authors:  Alicia T Widge; Nadine G Rouphael; Lisa A Jackson; Evan J Anderson; Paul C Roberts; Mamodikoe Makhene; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian B McDermott; Britta Flach; Bob C Lin; Nicole A Doria-Rose; Sijy O'Dell; Stephen D Schmidt; Kathleen M Neuzil; Hamilton Bennett; Brett Leav; Mat Makowski; Jim Albert; Kaitlyn Cross; Venkata-Viswanadh Edara; Katharine Floyd; Mehul S Suthar; Wendy Buchanan; Catherine J Luke; Julie E Ledgerwood; John R Mascola; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-12-03       Impact factor: 91.245

7.  What reinfections mean for COVID-19.

Authors:  Akiko Iwasaki
Journal:  Lancet Infect Dis       Date:  2020-10-12       Impact factor: 25.071

8.  Genomic evidence for reinfection with SARS-CoV-2: a case study.

Authors:  Richard L Tillett; Joel R Sevinsky; Paul D Hartley; Heather Kerwin; Natalie Crawford; Andrew Gorzalski; Chris Laverdure; Subhash C Verma; Cyprian C Rossetto; David Jackson; Megan J Farrell; Stephanie Van Hooser; Mark Pandori
Journal:  Lancet Infect Dis       Date:  2020-10-12       Impact factor: 25.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.